Top Markets
#1 EXOD EXOD +22.08%
#2 Geodnet Geodnet +17.63%
#3 Ontology Gas Ontology Gas +17.44%
#4 XPIN Network XPIN Network +17.03%
#5 Derive Derive +15.73%
#6 Status Status +13.62%
#7 Neiro Neiro +12.53%
#8 Pons Pons +12.37%
#9 Collect on Fanable Collect on Fanable +11.77%
#10 AUKI AUKI +9.94%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
StemCell Institute Inc. StemCell Institute Inc.

StemCell Institute Inc.

7096
Rank in Stocks #25357
StemCell Institute Inc. provides specialized stem cell banking services... StemCell Institute Inc. provides specialized stem cell banking services throughout Japan. In addition to its core preservation activities, the company is deeply involved in the research and development of medical therapies that utilize stem cells, and it also offers banking solutions for blood vessel cells. Founded in 1999, StemCell Institute Inc. is headquartered in Tokyo, Japan, and operates as a subsidiary of Trim Medical Holdings Inc.
Share Price
$4.97
Market Cap
$50.06M
Change (1 day)
-1.68%
Change (1 year)
-28.05%
Country
JP
Trade StemCell Institute Inc. (7096)

Category

Healthcare
P/B ratio for StemCell Institute Inc. (7096)
P/B ratio as of 2026 TTM: 0
According to StemCell Institute Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for StemCell Institute Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US